Cite
Discovery of an SSTR2-Targeting Maytansinoid Conjugate (PEN-221) with Potent Activity in Vitro and in Vivo.
MLA
White, Brian H., et al. “Discovery of an SSTR2-Targeting Maytansinoid Conjugate (PEN-221) with Potent Activity in Vitro and in Vivo.” Journal of Medicinal Chemistry, vol. 62, no. 5, Mar. 2019, pp. 2708–19. EBSCOhost, https://doi.org/10.1021/acs.jmedchem.8b02036.
APA
White, B. H., Whalen, K., Kriksciukaite, K., Alargova, R., Au Yeung, T., Bazinet, P., Brockman, A., DuPont, M., Oller, H., Lemelin, C.-A., Lim Soo, P., Moreau, B., Perino, S., Quinn, J. M., Sharma, G., Shinde, R., Sweryda-Krawiec, B., Wooster, R., & Bilodeau, M. T. (2019). Discovery of an SSTR2-Targeting Maytansinoid Conjugate (PEN-221) with Potent Activity in Vitro and in Vivo. Journal of Medicinal Chemistry, 62(5), 2708–2719. https://doi.org/10.1021/acs.jmedchem.8b02036
Chicago
White, Brian H, Kerry Whalen, Kristina Kriksciukaite, Rossitza Alargova, Tsun Au Yeung, Patrick Bazinet, Adam Brockman, et al. 2019. “Discovery of an SSTR2-Targeting Maytansinoid Conjugate (PEN-221) with Potent Activity in Vitro and in Vivo.” Journal of Medicinal Chemistry 62 (5): 2708–19. doi:10.1021/acs.jmedchem.8b02036.